Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Loop Capital Analyst Reaffirms Hold Rating for Ulta Beauty with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Food Retailers Trading online
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On March 15, 2024, Loop Capital analyst Anthony Chukumba reaffirmed a Hold rating for Ulta Beauty and increased the price target to $540, up from $530. This adjustment signifies Loop Capital’s positive outlook on Ulta Beauty’s market performance and growth potential.

__________________________________________________________________________________________________

ULTA Beauty Inc. Stock Price Drops: What Investors Need to Know

On March 15, 2024, ULTA Beauty Inc. (ULTA) experienced a significant drop in its stock price, with shares decreasing by $22.38, or 3.96%, since the previous market close. The stock opened at $503.85, which was $61.59 lower than its previous close. Despite this drop in price, ULTA is still trading near the top of its 52-week range and above its 200-day simple moving average. Investors may be wondering what caused this drop in ULTA’s stock price. There could be a variety of factors at play, such as overall market conditions, company-specific news, or changes in investor sentiment. It’s important for investors to conduct thorough research and analysis before making any decisions about buying or selling ULTA stock. Stock prices can be volatile and subject to fluctuations on a daily basis. While a single day’s performance is important to consider, it’s essential to look at the bigger picture and consider the stock’s performance over a longer period of time. Overall, ULTA’s stock performance on March 15, 2024, may have been disappointing for some investors, but it’s important to keep in mind the broader context of the stock’s performance and to make investment decisions based on thorough research and analysis.

ULTA Beauty Stock Performance Reflects Mixed Financial Results: Revenue Up, Net Income Down

On March 15, 2024, ULTA Beauty saw its stock performance reflect its recent financial results. ULTA reported total revenue of $11.21 billion for the past year, with a quarterly revenue of $2.49 billion, representing a 9.78% increase in total revenue since last year. However, the revenue held flat since the last quarter.

ULTRA reported a net income of $1.29 billion for the past year, with a quarterly net income of $249.48 million, indicating a 3.91% increase in net income since last year, but a significant 16.87% decrease since the last quarter.

Earnings per share (EPS) for ULTA were reported at $24.01 for the past year and $5.07 for the last quarter, representing a 33.58% increase in EPS since last year, but a 15.82% decrease since the last quarter.

The mixed financial results for ULTA Beauty have likely impacted its stock performance on March 15, 2024. Investors may be cautious about the company’s ability to maintain revenue growth and profitability in the face of changing market conditions. The decrease in net income and EPS since the last quarter may have raised concerns among investors about the company’s financial health.

It will be interesting to see how ULTA Beauty navigates these challenges and whether it can regain momentum in the coming quarters. Investors will likely be closely monitoring the company’s financial performance and strategic initiatives to assess its long-term growth prospects.

Tags: ULTA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

The Power of Compounded Returns A Case Study of Union Pacific Stock

Alternative Energy Stock Market Today

Lithium Market Dynamics Key Players Adapt to Changing Conditions

Finance_Commercial

First Mid Bancshares Inc Files for 200 Million Mixed Shelf Offering with SEC

Recommended

Amazon Stock

Amazon’s AI Ambitions: Strategic Pivot or Costly Gamble?

5 months ago
BAE Systems Stock

BAE Systems Navigates Labor Challenges Amid Record Contract Backlog

5 months ago
Biotechnology Stock Bull Market

B of A Securities Upgrades Apple to Buy Expects Growth with AI and Vision Pro

2 years ago
BioNTech Stock

Can BioNTech Reinvent Itself Beyond the Pandemic?

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

SuRo Capital Sharpens Focus on AI Infrastructure Investments

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Trending

Ammo Stock
Analysis

Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test

by Jackson Burston
February 8, 2026
0

The upcoming quarterly report from Outdoor Holding Company, formerly known as Ammo, represents a critical milestone. Investors...

Berry Petroleum Stock

California Resources Navigates Post-Merger Integration and Regulatory Landscape

February 8, 2026
KemPharm Stock

Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

February 8, 2026
Oak Valley Stock

Oak Valley Bancorp Surpasses $2 Billion Milestone with Record Annual Profit

February 8, 2026
SuRo Capital Stock

SuRo Capital Sharpens Focus on AI Infrastructure Investments

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Outdoor Holding Company’s Pivot Faces Crucial Quarterly Test
  • California Resources Navigates Post-Merger Integration and Regulatory Landscape
  • Zevra Therapeutics Advances Rare Disease Portfolio with New Data and Strategic Expansion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com